Salvatore Giovine

2022

In 2022, Salvatore Giovine earned a total compensation of $693.2K as Former Chief Financial Officer at Xilio Therapeutics, a 64% decrease compared to previous year.

Compensation breakdown

Option Awards$436,793
Salary$256,154
Other$252
Total$693,199

Giovine received $436.8K in option awards, accounting for 63% of the total pay in 2022.

Giovine also received $256.2K in salary and $252 in other compensation.

Rankings

In 2022, Salvatore Giovine's compensation ranked 3,801st out of 5,760 executives tracked by ExecPay. In other words, Giovine earned more than 34.0% of executives.

ClassificationRankingPercentile
All
3,801
out of 5,760
34th
Division
Manufacturing
2,153
out of 3,136
31st
Major group
Chemicals And Allied Products
1,037
out of 1,422
27th
Industry group
Drugs
973
out of 1,323
27th
Industry
Pharmaceutical Preparations
712
out of 969
27th
Source: SEC filing on April 25, 2023.

Giovine's colleagues

We found two more compensation records of executives who worked with Salvatore Giovine at Xilio Therapeutics in 2022.

2022

René Russo

Xilio Therapeutics

Chief Executive Officer

2022

Martin Huber

Xilio Therapeutics

President and Head of R&D

News

In-depth

You may also like